| PERIOD ENDING | 26-Dec-09 | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | | Total Revenue | 2,858,000 | 2,588,000 | 3,164,000 | 3,028,000 | | Cost of Revenue | 1,753,000 | 1,619,000 | 1,960,000 | 1,886,000 | | | Gross Profit | 1,105,000 | 969,000 | 1,204,000 | 1,142,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 791,000 | 631,000 | 870,000 | 864,000 | | Non Recurring | 32,000 | 13,000 | 269,000 | 16,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 282,000 | 325,000 | 65,000 | 262,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6,000 | 6,000 | 7,000 | 11,000 | | Earnings Before Interest And Taxes | 288,000 | 331,000 | 72,000 | 273,000 | | Interest Expense | 38,000 | 35,000 | 38,000 | 45,000 | | Income Before Tax | 250,000 | 296,000 | 34,000 | 228,000 | | Income Tax Expense | (55,000) | 106,000 | 48,000 | 63,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 305,000 | 190,000 | (14,000) | 165,000 | | | Non-recurring Events | | Discontinued Operations | 66,000 | 94,000 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 371,000 | 284,000 | (14,000) | 165,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $371,000 | $284,000 | ($14,000) | $165,000 |
|
1.52% Nasdaq 
Income Statement
